Alkem Laboratories is engaged in pharmaceutical business with global operations. The Company is engaged in the development, manufacture and sale of pharmaceutical and nutraceutical products.
Financial Results:
Alkem Laboratories Ltd reported Revenues for Q1FY25 of ₹3,032.00 Crores up from ₹2,968.00 Crore year on year, a rise of 2.16%.
Total Expenses for Q1FY25 of ₹2,532.00 Crores down from ₹2,681.00 Crores year on year, a fall of 5.56%.
Consolidated Net Profit of ₹550.00 Crores up 90.97% from ₹288.00 Crores in the same quarter of the previous year.
The Earnings per Share is ₹45.60, up 90.16% from ₹23.98 in the same quarter of the previous year.
*It is important to note that the way the results have been accounted for are slightly different than the ones the companies may choose to publish.
*The presented data is automatically generated. It may occasionally generate incorrect information.